ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Recursos principais

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Invesco Variable Rate Preferred ETF

Invesco Variable Rate Preferred ETF (VRP)

24,535
-0,015
( -0,06% )
Atualizado: 15:11:16

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Estatísticas e detalhes chave

Último Preço
24,535
Preço de Compra
-
Preço de Venda
-
Volume Negociado da Ação
145.623
24,52 Faixa do Dia 24,5899
21,60 Faixa de 52 semanas 24,66
Capitalização de Mercado [m]
Preço Anterior
24,55
Preço de Abertura
24,57
Negócios
1
@
24.53
Última hora de negociação
15:20:28
Volume financeiro
US$ 3.573.451
Preço Médio Ponderado
24,5391
Volume médio (3 m)
384.064
Ações em circulação
66.000.000
Rendimento do Dividendo
-
Relação Preço/Lucro
23,60
Lucro por ação (LPA)
1,04
Receita
97,39M
Lucro líquido
68,63M

Sobre Invesco Variable Rate Preferred ETF

The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a m... The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a market capitalization-weighted index designed to track the performance of preferred stock, as well as certain types of hybrid securities that are functionally equivalent to preferred stocks, that are issued by U.S.-based or foreign issuers and that pay a floating or variable rate dividend or coupon. It is non-diversified. Mostrar mais

Setor
Mgmt Invt Offices, Open-end
Indústria
Mgmt Invt Offices, Open-end
Sede
Wilmington, Delaware, USA
Fundado
-
Invesco Variable Rate Preferred ETF faz parte do setor Mgmt Invt Offices, Open-end de American Stock Exchange com o ticker VRP. O preço do último fechamento da empresa Invesco Variable Rate Pr... foi US$24,55. Invesco Variable Rate Pr... atualmente tem 66.000.000 ações em Circulação. Durante o ano, Invesco Variable Rate Pr... as ações foram negociados entre US$ 21,60 e US$ 24,66.

Invesco Variable Rate Pr... atualmente tem 66.000.000 ações em Circulação. O valor de mercado da empresa Invesco Variable Rate Pr... é US$1,62 bilhões. Invesco Variable Rate Pr... tem o preço/lucro de 23.60.

Últimas Notícias de VRP

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verona Pharma plc (Nasdaq: VRNA), please note that all instances of the...

Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

Primary and secondary lung function endpoints met Results support twice-daily dosing LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona...

Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD Completed $200 million private placement Commenced a pilot clinical study in U.S. patients hospitalized with COVID-19 Conference call today at...

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...

LONDON and RALEIGH, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

PeríodoVarVar %AbeMáx.Mín.Vol Méd.VWAP diário
1-0.075-0.30475416497424.6124.6624.4135091724.53148106SP
40.3151.3005780346824.2224.6624.16528409824.442236SP
120.4852.0166320166324.0524.6623.4338406424.0880513SP
260.7052.9584557280723.8324.6623.440131723.9089811SP
522.1159.4335414808222.4224.6621.638363223.41808246SP
156-1.755-6.6755420311926.2926.3120.87543361323.32527938SP
260-0.895-3.5194651985825.4326.513.3339692223.79795678SP

Rankings

Ver todos
  • Volume
  • % Altas
  • % Quedas
CódigoPreçoVol.
AMBP3Ambipar Participacoes e Empreendimentos SA
R$ 129,50
(22,15%)
465,6k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.
R$ 2,31
(17,86%)
11,99M
VALE3QVale SA
R$ 64,85
(10,85%)
981k
AZEV3Azevedo Travassos Sa
R$ 1,35
(10,66%)
1,28M
CGAS3Cia Gas Sao Paulo Comgas
R$ 127,00
(10,43%)
100
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0,01
(-50,00%)
86,3M
CEED4Cia Estadual Distribuicao Energia Eletrica Ceee-d
R$ 20,00
(-20,00%)
100
PTNT3Pettenati Sa Ind Textil
R$ 10,02
(-14,36%)
1,8k
RCSL3Recrusul Sa
R$ 4,94
(-13,18%)
2,41M
JOPA3Josapar Joaquim Oliveira Sa Participacoes
R$ 21,11
(-8,22%)
100
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0,02
(0,00%)
86,09M
HAPV3Hapvida Participacoes Investimento SA
R$ 4,01
(-1,23%)
37,3M
BBDC4Bco Bradesco Sa
R$ 15,03
(1,55%)
32,57M
AZUL4AZUL SA
R$ 5,90
(5,36%)
29,5M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36,20
(-0,357831%)
24,66M
Nenhuma Discussão Encontrada
Criar Nova Discussão